Solesence (NASDAQ:SLSN) Posts Earnings Results

Solesence (NASDAQ:SLSN – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.05 earnings per share (EPS) for the quarter, FiscalAI reports. Solesence had a negative return on equity of 11.58% and a negative net margin of 3.40%. The business had revenue of $20.16 million for the quarter.

Solesence Trading Down 0.2%

Shares of NASDAQ:SLSN traded down $0.00 during mid-day trading on Thursday, reaching $0.91. The stock had a trading volume of 1,509,723 shares, compared to its average volume of 57,892. The firm has a 50 day simple moving average of $0.85 and a two-hundred day simple moving average of $1.05. Solesence has a twelve month low of $0.61 and a twelve month high of $2.30. The firm has a market cap of $64.22 million, a PE ratio of -30.30 and a beta of 1.32.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Solesence in a report on Monday, October 26th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Read Our Latest Stock Analysis on SLSN

Institutional Investors Weigh In On Solesence

Several large investors have recently bought and sold shares of SLSN. Susquehanna International Group LLP raised its holdings in Solesence by 697.7% in the second quarter. Susquehanna International Group LLP now owns 111,340 shares of the company’s stock worth $82,000 after purchasing an additional 97,382 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Solesence during the second quarter worth $233,000. Finally, BlackRock Inc. bought a new position in shares of Solesence during the second quarter worth $341,000. Institutional investors own 70.22% of the company’s stock.

About Solesence

(Get Free Report)

Solesence is a skincare company focused on developing science-based products designed to protect, improve and maintain the health and appearance of skin. Its work centers on combining cosmetic formulations with dermatological and cosmetic science, particularly in areas such as daily skin protection and visible signs of skin aging. The company develops skincare and sun-care formulations for use in branded and private-label products. Its offerings are intended to support needs including mineral sun protection, hydration, skin tone and texture, and anti-aging care.

Read More

Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.